Publications - Jean C . Fox, M.D.

Back to Research Profile

1. Szarka LA, Camilleri M, Burton D, Fox JC, McKinzie S, Stanislav T, Simonson J, Sullivan N, Zinsmeister AR. Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol 2007 Nov; 5(11):1268-75. Epub 2007 Sep 27.
   View PubMed
2. Fox JC, Fletcher JG, Zinsmeister AR, Seide B, Riederer SJ, Bharucha AE. Effect of aging on anorectal and pelvic floor functions in females (vol 49, pg 1726, 2006). Diseases of the Colon & Rectum 2007 Mar; 50(3):404.
   View PubMed
3. Fox JC, Fletcher JG, Zinsmeister AR, Seide B, Riederer SJ, Bharucha AE. Effect of aging on anorectal and pelvic floor functions in females. Dis Colon Rectum 2006 Nov; 49(11):1726-35.
   View PubMed
4. Camilleri M, McKinzie S, Fox J, Foxx-Orenstein A, Burton D, Thomforde G, Baxter K, Zinsmeister AR. Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2004 Oct; 2(10):895-904.
   View PubMed
5. Saito YA, Fox JC. Management of functional abdominal pain current treatment options. Gastroenterology 2004 Aug; 7(4):279-90.
6. Bharucha AE, Seide B, Fox JC, Croak AJ, Zinsmeister, AR. Reproducibility of anorectal function tests. Neurogastroenterology and Motility 2004 April; 16(2):241-50.
   View PubMed
7. Bharucha AE, Seide B, Fox JC, Zinsmeister AR. Day-to-day reproducibility of anorectal sensorimotor assessments in healthy subjects. Neurogastroenterology & Motility 2004 Apr; 16(2):241-50.
   View PubMed
8. Saito YA, Fox JC. Management of functional abdominal pain. Curr Treat Options Gastroenterol 2004; 7(4):279-90.
   View PubMed
9. Camilleri M, McKinzie S, Fox JC, Foxx-Orenstein A, Burton D, Thomforde G, Baxter K, Zinsmeister AR. A Randomized Controlled Trial of Renzapride on Colonic Motility in Patients with Constipation-Predominant Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology 2004.
10. Fox JC, Szyjkowski RS, Sanderson SO, Levine RA. Progressive cholestatic liver disease associated with clarithromycin treatment. J Clin Pharmacol 2002 Jun; 42(6):676-80.
    View PubMed